Page last updated: 2024-09-02

r 56865 and lidoflazine

r 56865 has been researched along with lidoflazine in 1 studies

Compound Research Comparison

Studies
(r 56865)
Trials
(r 56865)
Recent Studies (post-2010)
(r 56865)
Studies
(lidoflazine)
Trials
(lidoflazine)
Recent Studies (post-2010) (lidoflazine)
72102293714

Protein Interaction Comparison

ProteinTaxonomyr 56865 (IC50)lidoflazine (IC50)
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.0159
Equilibrative nucleoside transporter 1Homo sapiens (human)4.954

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgers, M; De Clerck, F; Vandewiele, R; Ver Donck, L; Verellen, G1

Other Studies

1 other study(ies) available for r 56865 and lidoflazine

ArticleYear
Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
    Cell biology international reports, 1990, Volume: 14, Issue:4

    Topics: Animals; Benzothiazoles; Calcium Channel Blockers; Cell Separation; Cinnarizine; Diltiazem; Flunarizine; Lidoflazine; Lipid Peroxidation; Malondialdehyde; Myocardium; Nicardipine; Oxygen; Piperidines; Rats; Thiazoles; Verapamil

1990
chemdatabank.com